Phase 3 prognostic analysis of the automated bone scan index (aBSI) in men with bone-metastatic castration-resistant prostate cancer (CRPC).

被引：4

作者：

Armstrong, Andrew J.

Edenbrandt, Lars

Bondesson, Eva

Anand, Aseem

Nordle, Orjan

Carducci, Michael Anthony

Morris, Michael J.

机构：

[1] Duke Univ, Duke Canc Inst, Div Med Oncol & Urol, Durham, NC USA

[2] Sahlgrens Univ Hosp, Gothenburg, Sweden

[3] EXINI Diagnost, Lund, Sweden

[4] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[5] Nordle Biostat Consultancy, Rydeback, Sweden

[6] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[7] Weill Cornell Med Coll, New York, NY USA

来源：

关键词：

D O I：

10.1200/JCO.2017.35.15_suppl.5006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5006

引用

页数：5